Does AMISULPRIDE Cause Hyperprolactinaemia? 135 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Hyperprolactinaemia have been filed in association with AMISULPRIDE (Barhemsys). This represents 4.3% of all adverse event reports for AMISULPRIDE.
135
Reports of Hyperprolactinaemia with AMISULPRIDE
4.3%
of all AMISULPRIDE reports
1
Deaths
50
Hospitalizations
How Dangerous Is Hyperprolactinaemia From AMISULPRIDE?
Of the 135 reports, 1 (0.7%) resulted in death, 50 (37.0%) required hospitalization.
Is Hyperprolactinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Therapeutic product effect incomplete (200)
Off label use (191)
What Other Drugs Cause Hyperprolactinaemia?
RISPERIDONE (4,124)
PALIPERIDONE (1,427)
OLANZAPINE (520)
ARIPIPRAZOLE (459)
QUETIAPINE (331)
HALOPERIDOL (214)
CLOZAPINE (157)
SERTRALINE (120)
LITHIUM (76)
VENLAFAXINE (71)
Which AMISULPRIDE Alternatives Have Lower Hyperprolactinaemia Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE